Skip to content

Study on the mechanism of cognitive impairment in patients with burning mouth syndrome

Study on the mechanism of cognitive impairment in patients with burning mouth syndrome

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500095170
Enrollment
Unknown
Registered
2025-01-02
Start date
2022-09-22
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Burning mouth syndrome

Interventions

Burning mouth syndrome patient group:None
Healthy control group:None

Sponsors

College & Hospital of Stomatology, Guangxi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria for the BMS group: patients experiencing the symptoms of oral burning recurring daily for >2h per day for >3 months without clinically evident causative lesions; patients aged between 40 and 80; patients with normal blood test findings (including blood count, liver and kidney functions, blood glucose levels and glycated hemoglobin, thyroid function, vitamin B12, serum ferritin and folic acid); patients understanding the questionnaire and participating voluntarily. Health group: healthy controls with the normal oral mucosa; healthy controls with age, gender, body mass index (BMI) and education level were basically matched with BMS patients.

Exclusion criteria

Exclusion criteria: Exclusion criteria for the BMS group: patients with a history of mental disorder or neurological or organic brain dysfunction, obstructive sleep apnoa syndrome, severe and uncontrolled systemic disease, or malignancy; patients undergoing the treatment with psychotropic drugs, or having used immunosuppressants in the last 3 months or antibiotics in the last 1 month; patients with a history of alcohol, smoking or drug abuse; patients with periodontitis, oral candidiasis and other oral mucosal diseases or inflammation. Exclusion criteria for the healthy group were similar to those for the BMS group.

Design outcomes

Primary

MeasureTime frame
Cognitive function;Biomarkers (Proteomics, Microbiome);

Secondary

MeasureTime frame
Anxiety/Depression;Sleep index;

Countries

China

Contacts

Public ContactXiaojie Lin

College & Hospital of Stomatology, Guangxi Medical University

lin-xiao-jie-618@163.com+86 771 238 7321

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026